Plasma metabolomic profile in fibrosing pulmonary sarcoidosis.
Mehdi Mirsaeidi(Jacksonville University), Roberto F. Machado(University of Maryland, Baltimore), Anoushirvan Hakim(University of Illinois Chicago), Robert P. Baughman(University of Cincinnati), Caleb K. Nienow(University of Illinois Chicago), Joe G. N. Garcia(Scripps Research Institute), Mohammad Mehdi Banoei(University of Calgary), Brent W. Winston(University of Calgary), Taimur Abassi(University of Illinois Chicago), Nadera Sweiss(University of Illinois Chicago), Dean E. Schraufnagel(University of Illinois Chicago)
PubMed
March 29, 2016
Cited by 22
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503